Compliance Radar

Who was sanctioned, and for what?

Fines, court rulings and incidents from Europe and North America: 756 cases from 32 jurisdictions, each with an official source and checked against that source before publication. Filter by country, area of law and sector. Click a chart to drill down one level.

2cases from 1 jurisdiction
€22.3mTotal of monetary amounts
€11.2mMedian per case with an amount

Click a bar to drill down one level.

When?

per quarter, by date of decision
Trend
PeriodCasesTotal
Q3 20230—
Q4 20230—
Q1 20240—
Q2 20240—
Q3 20240—
Q4 20240—
Q1 20250—
Q2 20250—
Q3 20250—
Q4 20250—
Q1 20261€7.8m
Q2 20261€14.6m
Q3 20260—

2 cases

17 Apr 2026 Medirex s. r. o.; KLINICKÁ BIOCHÉMIA s.r.o.; Unilabs Slovensko, s. r. o.; synlab slovakia s. r. o.; Asociácia laboratóriíLaboratory cartel: 14.6 million EUR and procurement bans against diagnostic laboratories SlovakiaCartels and collusion €14.6m

Four laboratories and their association coordinated negotiations on prices with health insurers, coordinated in tenders, exchanged sensitive information and allocated customers. At first instance, the Protimonopolný úrad Slovenskej republiky (Antimonopoly Office of the Slovak Republic, PMÚ SR) imposed 14,551,800 EUR and three-year procurement bans; Unilabs received a substantially reduced fine as leniency applicant and under a settlement.

What organisations can take from it

Common negotiating positions towards payers via an association are a cartel – association meetings need minutes and a review of the agenda.

Relevance to training and awareness

Information exchange among competitors and association work

Authority / court
Protimonopolný úrad Slovenskej republiky (PMÚ SR)
Area of law
Competition law · Cartels and collusion
Legal basis
Slowakisches Wettbewerbsschutzgesetz (Kartellverbot)
Action
Fine
Status of proceedings
unknown
Sector
Healthcare
Culpability
intentional
Mitigating circumstances
Unilabs: leniency reduction (50%) and settlement (a further 30%).
Published
12 May 2026

Checked against the official source on 25 Sep 2026 · Direct link

Report an error

Anonymous: we store only your text — no contact details and no IP address.

20 Jan 2026 PHOENIX Zdravotnícke zásobovanie, a.s.; TRANSMEDIC SLOVAKIA, s.r.o. (in Konkurs)Pharmaceutical cartel uncovered thanks to whistleblower: 7.8 million EUR against PHOENIX and TRANSMEDIC SlovakiaCartels and collusion €7.8m

The two companies colluded in tenders of the General Health Insurance Company for the supply of medicines (2017–2020). For the first time, a cartel was uncovered on the basis of information from a whistleblower; the Protimonopolný úrad Slovenskej republiky (Antimonopoly Office of the Slovak Republic, PMÚ SR) imposed 7,595,200 EUR and a one-year procurement ban on PHOENIX and 201,800 EUR and a three-year procurement ban on TRANSMEDIC (first instance).

What organisations can take from it

Whistleblowers receive a reward in Slovakia – internal reporting channels should be faster than the route to the authority.

Relevance to training and awareness

Bid rigging in public tenders; whistleblowing channels

Authority / court
Protimonopolný úrad Slovenskej republiky (PMÚ SR)
Area of law
Competition law · Cartels and collusion
Legal basis
Slowakisches Wettbewerbsschutzgesetz (Submissionsabsprache)
Action
Fine
Status of proceedings
unknown
Sector
Healthcare
Culpability
intentional
Mitigating circumstances
PHOENIX: settlement with a 30% fine reduction and a shortened procurement ban.
Published
24 Feb 2026

Checked against the official source on 25 Sep 2026 · Direct link

Report an error

Anonymous: we store only your text — no contact details and no IP address.

Ready for training that sticks?

Try it free for 14 days — from 1 user, no credit card, ends automatically.

Start free trial